Home » Topics » Regulatory » Patents

Patents
RSS

New oxazolidinones claimed by Zeneca (AstraZeneca)

April 30, 1999

Merck researchers prepare potential antipsychotic compounds with reduced side effects

April 30, 1999

Inhibitors of 5alpha-reductase claimed by L'Oreal for androgen-dependent skin disorders

April 30, 1999

Protease inhibitors in development at SmithKline Beecham

April 30, 1999

Urea-based compounds from AHP increase HDL cholesterol levels

April 30, 1999

DuPont presents new series of HIV reverse transcriptase inhibitors

April 30, 1999

HMR describes new NCBE inhibitor series for cardiovascular disorders

April 29, 1999

Pyrazoles acting as modulators of cGMP production disclosed by Hoechst Marion Roussel

April 29, 1999

Triazine-based adenosine antagonists in development at Boehringer Ingelheim

April 29, 1999

New CRF antagonists described by DuPont for stress-related disorders

April 29, 1999

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...